Negara: Indonesia
Bahasa: Bahasa Indonesia
Sumber: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN, HUMAN PAPI
ORGANON PHARMA INDONESIA TBK - Indonesia
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN, HUMAN PAPI
30 MCG /40 Mcg /60 MCG /40 MCG /20 MCG /20 MCG /20 MCG /20 MCG /20 Mcg
SUSPENSI INJEKSI
DUS, 1 PREFILLED SYRINGE @ 0,5 ML
MERCK SHARP & DOHME CORP. - United States of America
2021-09-11
GARDASIL9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Suspension for Injection 1. NAME OF THE MEDICINAL PRODUCT GARDASIL 9 suspension for injection Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose (0.5 ml) contains approximately: Human Papillomavirus 1 Type 6 L1 protein 2,3 30 micrograms Human Papillomavirus 1 Type 11 L1 protein 2,3 40 micrograms Human Papillomavirus 1 Type 16 L1 protein 2,3 60 micrograms Human Papillomavirus 1 Type 18 L1 protein 2,3 40 micrograms Human Papillomavirus 1 Type 31 L1 protein 2,3 20 micrograms Human Papillomavirus 1 Type 33 L1 protein 2,3 20 micrograms Human Papillomavirus 1 Type 45 L1 protein 2,3 20 micrograms Human Papillomavirus 1 Type 52 L1 protein 2,3 20 micrograms Human Papillomavirus 1 Type 58 L1 protein 2,3 20 micrograms 1 Human Papillomavirus = HPV. 2 L1 protein in the form of virus-like particles produced in yeast cells ( Saccharomyces cerevisiae CANADE 3C-5 (Strain 1895)) by recombinant DNA technology. 3 Adsorbed on amorphous aluminium hydroxyphosphate sulphate adjuvant (0.5 milligrams Al). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection. Clear liquid with white precipitate. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Girls and Women GARDASIL 9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of the following diseases: − Cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types 16, 18,31, 33, 45, 52, and 58 − Genital warts (condyloma acuminata) caused by HPV types 6 and 11 And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: − Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS) − Cervical intraepithelial neoplasia (CIN) grade 1 − Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3 − Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3 − Anal intraepithe Baca dokumen lengkapnya